Skip to main content

Basel Medical Group Ltd

For the period ended Aug 10, 2026. Filed Aug 10, 2026.

View on SEC.gov

About this filing

What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.

Aug 10, 2026 · Filed Aug 10, 2026

Use the contents to explore the available documents and sections.

BMGL$5.29+1.9%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Explanatory Note

On July 23, 2026, a securities class action complaint (the “Action”) was filed in the Supreme Court of the State of New York, County of New York, naming as defendants more than 30 publicly traded companies in the U.S., including Basel Medical Group Ltd (the “Company”), more than 10 broker-dealer firms in the U.S. and certain other named individuals. The summons and complaint were served on the process agent of the Company on August 5, 2026. The Company is currently reviewing the merits of such Action. The action is at an early stage and the Company is unable to predict such contingency or estimate any likely outcome at this time.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.